Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
This study is currently recruiting participants.
Verified January 2013 by Novartis
Study NCT01544595
Information provided by Novartis
First Received on February 28, 2012.
Last Updated on January 18, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
